150 related articles for article (PubMed ID: 5524122)
1. Lung volume changes following treatment with corticosteroids in patients with bronchial asthma.
Stanescu D; Popescu IG; Teculescu D
Allerg Asthma (Leipz); 1970; 16(6):238-42. PubMed ID: 5524122
[No Abstract] [Full Text] [Related]
2. [Maritime climate therapy. Pulmonary function in patients with bronchial asthma].
Lazarus P
Allerg Asthmaforsch; 1969; 6():141-55. PubMed ID: 5384967
[No Abstract] [Full Text] [Related]
3. Four strategies for treating asthma.
Tisi GM
Med Times; 1980 Apr; 108(4):2S-4S, 9S-10S, 16S-18S. PubMed ID: 7360032
[No Abstract] [Full Text] [Related]
4. [Studies before and after vagosympathicotomy in bronchial asthma].
Mürtz R; Wittmoser R; Ashba J
Med Welt; 1967 Mar; 12():681-6. PubMed ID: 5586324
[No Abstract] [Full Text] [Related]
5. [Indicators of external respiration in complex treatment of bronchial asthma].
Dumka RN; Neĭko EM; Basatskiĭ VM
Vrach Delo; 1975 Jun; (6):100-1. PubMed ID: 1154709
[No Abstract] [Full Text] [Related]
6. Progress of asthma and adrenocortical function.
Nathoo AR
Br J Dis Chest; 1971 Apr; 65(2):85-90. PubMed ID: 4325027
[No Abstract] [Full Text] [Related]
7. [Conditioning factors for corticotherapy of non-seasonal asthma. Usefulness of bronchial hyperreactivity].
de Barrio M; Gozalo F; Senent C; Colás C; Redondo G; Pelta R
Med Clin (Barc); 1986 Mar; 86(11):450-3. PubMed ID: 3713307
[No Abstract] [Full Text] [Related]
8. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C
Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745
[TBL] [Abstract][Full Text] [Related]
9. The variability of regional airflow obstruction within the lungs of patients with asthma: assessment with hyperpolarized helium-3 magnetic resonance imaging.
de Lange EE; Altes TA; Patrie JT; Parmar J; Brookeman JR; Mugler JP; Platts-Mills TA
J Allergy Clin Immunol; 2007 May; 119(5):1072-8. PubMed ID: 17353032
[TBL] [Abstract][Full Text] [Related]
10. Acute bronchial asthma. Relations between clinical and physiologic manifestations.
McFadden ER; Kiser R; DeGroot WJ
N Engl J Med; 1973 Feb; 288(5):221-5. PubMed ID: 4682217
[No Abstract] [Full Text] [Related]
11. [The serum testosterone level of patients with bronchial asthma treated with corticosteroids and untreated].
Mileva Zh; Maleeva A
Vutr Boles; 1988; 27(4):29-32. PubMed ID: 3213021
[TBL] [Abstract][Full Text] [Related]
12. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.
Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ
J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970
[TBL] [Abstract][Full Text] [Related]
13. Normal lung function in children with mild to moderate persistent asthma well controlled by inhaled corticosteroids.
Baatenburg de Jong A; Brouwer AF; Roorda RJ; Brand PL
J Allergy Clin Immunol; 2006 Jul; 118(1):280-2. PubMed ID: 16815168
[No Abstract] [Full Text] [Related]
14. Five-year changes in airflow obstruction and airway responsiveness in mild to moderate asthma.
Boulet LP; Jobin C; Milot J; Turcotte H
Clin Invest Med; 1994 Oct; 17(5):432-42. PubMed ID: 7867248
[TBL] [Abstract][Full Text] [Related]
15. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
[TBL] [Abstract][Full Text] [Related]
16. Influence of treatment on the nose and/or the lungs.
Pauwels R
Clin Exp Allergy; 1998 Jun; 28 Suppl 2():37-40. PubMed ID: 9678825
[TBL] [Abstract][Full Text] [Related]
17. [The beginning of water-soluble corticosteroid action in an asthma attack].
Reinert M
MMW Munch Med Wochenschr; 1976 Mar; 118(11):335-6. PubMed ID: 817159
[No Abstract] [Full Text] [Related]
18. Clinical course of bronchial asthma after respirator treatment.
Heikkinen V; Alanko K
Ann Chir Gynaecol Fenn; 1973; 62(5):277-80. PubMed ID: 4592559
[No Abstract] [Full Text] [Related]
19. Eosinophil cationic protein in serum of corticosteroid-sensitive and resistant bronchial asthma.
Patkowski J; Wytrychowski K; Medrala W
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):195-200. PubMed ID: 9597087
[TBL] [Abstract][Full Text] [Related]
20. Effects of a selective beta 2-receptor stimulant on lung function, intrapulmonary gas exchange and circulation at rest and during work in patients with bronchial asthma.
Koch G
Postgrad Med J; 1971 Mar; 47():Suppl:105-9. PubMed ID: 5572507
[No Abstract] [Full Text] [Related]
[Next] [New Search]
